老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADC Therapeutics SA

2.85
+0.05001.79%
盘后：2.78-0.0700-2.46%16:52 EDT
成交量：32.36万
成交额：90.68万
市值：2.83亿
市盈率：-1.97
高：2.85
开：2.83
低：2.74
收：2.80
数据加载中...
总览公司新闻资讯公告
2021/08/03

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/21

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
更多